Icagen Reaffirms Recommendation to Shareholders to Tender Shares

Icagen ICGN announced today that it has sent the following letter to stockholders affirming the Board's recommendation after receiving a letter from Pfizer PFE on Friday, August 26, 2011 stating that Pfizer's best and final offer price is $6.00 per share:
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsM&ABiotechnologyHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!